What Researchers Did
Researchers retrospectively analyzed a hyperbaric oxygen therapy registry to identify factors associated with residual symptoms after treatment for type I decompression sickness.
What They Found
Out of 195 patients, 131 (67.2%) experienced residual symptoms after a single hyperbaric oxygen therapy session. A longer delay from symptom onset to recompression was significantly associated with residual symptoms, with those treated after 240 hours having an adjusted odds ratio of 22.83. Commercial and recreational divers also showed a higher probability of residual symptoms compared to military divers.
What This Means for Canadian Patients
Canadian patients experiencing type I decompression sickness should seek hyperbaric oxygen therapy as quickly as possible to improve their chances of complete symptom resolution. Prompt treatment may reduce the likelihood of persistent symptoms after a single therapy session.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
This was a retrospective study, which inherently limits the ability to establish causality and control for all confounding factors.